Four reasons, in rough order of frequency: a raw material got restricted or banned, a raw material got expensive or unavailable, a captive molecule was discontinued, or someone decided the formula cost too much. Regulation gets the blame for all four. Only the first is actually regulatory.
Which rules actually bind, and which do not?
This distinction is the whole subject, and almost every popular account gets it wrong.
The EU Cosmetics Regulation, Regulation (EC) No 1223/2009, is law. Its Annex II lists substances prohibited in cosmetic products. Its Annex III lists substances subject to restriction — concentration limits, conditions of use, or labelling requirements. A product containing an Annex II substance cannot legally be sold in the EU regardless of who made it or whether they belong to any trade body.
IFRA Standards are not law. They are the International Fragrance Association’s self-regulatory program, binding on IFRA members and, in practice, on anyone whose customers demand an IFRA certificate — which is most of the supply chain. The Washington Post reported in 2021 that an estimated 80 to 90 percent of the perfume industry are IFRA members and follow its standards. The practical effect approaches that of law without being it: a non-member artisan in the United States selling direct is not bound by an IFRA Standard, while a supplier shipping concentrate to a multinational effectively is.
In the United States, fragrance-specific allergen rules do not yet exist. The Modernization of Cosmetics Regulation Act directs the FDA to issue regulations identifying fragrance allergens requiring label disclosure and to set disclosure thresholds. As of early 2026 the FDA had not issued them. So the reformulations American consumers notice are almost always driven by EU law or IFRA Standards applied globally, because brands would rather run one formula than two.
The two systems also do different things, which is a distinction worth holding onto. IFRA sets maximum use concentrations by product category. The EU’s allergen provisions in Annex III mostly set labelling obligations, not concentration caps: as one industry analysis puts it, “the final concentration of these fragrance allergens in the finished product is not restricted” by the Regulation itself. So when a fragrance gets weaker in a specific note, the cause is usually an IFRA ceiling, not an EU cap.
What has IFRA actually restricted or banned?
IFRA Standards come in three kinds: prohibitions, restrictions with a maximum use level by product category, and specifications setting purity or composition requirements on a material. The whole set is revised in numbered Amendments.
The 51st Amendment, notified on 30 June 2023, added 48 new Standards and revised 11. Of the 48 new Standards, exactly one was a prohibition: 3-acetyl-2,5-dimethylfuran, CAS 10599-70-9, on genotoxicity grounds. Thirty-two were restrictions for dermal sensitization, eleven were restrictions derived from the second-generation quantitative risk assessment methodology, two used a threshold of toxicological concern approach, one addressed depigmentation, and one was a specification.
| Milestone | Date | Applies to |
|---|---|---|
| 51st Amendment notified | 30 June 2023 | All IFRA members |
| Compliance with new Prohibition Standard | 30 August 2023 | New creations |
| Compliance with Restriction and Specification Standards | 30 March 2024 | New creations |
| Compliance with new Prohibition Standard | 30 July 2024 | Existing creations already on sale |
| Compliance with Restriction and Specification Standards | 30 October 2025 | Existing creations already on sale |
| 52nd Amendment consultation opened | 12 December 2025 | Industry consultation |
| 52nd Amendment consultation closed | 12 June 2026 | Industry consultation |
| End of Consultation Letter published | 31 August 2026 | Industry |
| 52nd Amendment notification expected | January 2027 | All IFRA members |
| 52nd Amendment compliance, new creations | 11 months after notification | New creations |
| 52nd Amendment compliance, existing creations | 30 months after notification | Existing creations |
The 52nd Amendment is the one currently driving reformulation work. IFRA’s End of Consultation Letter, published 31 August 2026, describes 48 new Restriction Standards addressing dermal sensitization — 37 of them with a systemic toxicity evaluation — plus 15 revised restriction standards and the withdrawal of two proposed standards. Notification is expected in January 2027. That means fragrances on shelves in 2027 and 2028 will be reformulated against rules that were already settled in 2026, which is the ordinary rhythm of this industry: the change reaches your nose two to three years after the decision.
What has the EU actually banned?
| Instrument | What it did | Dates |
|---|---|---|
| Commission Regulation (EU) 2017/1410 | Added HICC (Lyral), atranol and chloroatranol to Annex II; deleted HICC’s Annex III entry 79. Based on the SCCS opinion of 26-27 June 2012 that these were the fragrance allergens causing the highest number of contact allergy cases | Not placed on the EU market from 23 August 2019; not made available on the EU market from 23 August 2021 |
| Commission Regulation (EU) 2021/1902 (Omnibus IV) | Added butylphenyl methylpropional (BMHCA, Lilial, CAS 80-54-6) to Annex II as entry 1666, among substances classified as CMR under Delegated Regulation (EU) 2020/1182. The reproductive-toxicity category 1B classification comes from the CLP entry; the regulation itself does not name a sub-category in its recitals. It had previously been an Annex III labelled allergen | Applies from 1 March 2022, with no sell-off period |
| Commission Regulation (EU) 2023/1545 | Expanded individual fragrance allergen labelling. The recitals state that 24 allergens were previously individually labelled and that the SCCS identified 56 additional ones; the annex replaces 17 Annex III entries and adds 45 new entries (327-371), of which 21 are plant oils or extracts. Thresholds 0.001% leave-on, 0.01% rinse-off. Labelling only, not concentration caps | Placing on market from 31 July 2026; making available on market from 31 July 2028 |
| REACH authorisation decision | Musk xylene banned, announced 18 February 2011, on environmental persistence grounds. IFRA had already banned it under its own program | 2011 |
Two things about that table are worth stressing. The Lilial ban was a reproductive toxicity classification, not a skin sensitization decision — a completely different regulatory pathway from the one that catches most fragrance materials, and one with no sell-off period, which is why some products vanished from shelves rather than being reformulated. And 2023/1545 was a labelling measure, so it forced disclosure rather than removal. Its effect on formulas was indirect but real: brands that did not want a long allergen list on the box reduced or removed materials to stay under threshold.
Was oakmoss banned?
No. This is the most persistent error in fragrance writing, and getting it right matters because the actual mechanism is more interesting.
Oakmoss extract itself is restricted, not prohibited. The IFRA Standard for oakmoss extracts — covering CAS 90028-68-5, 68917-10-2 and 9000-50-4 — is a combined restriction and specification. The version currently published in IFRA’s Standards Library is the Amendment 49 text of 2020, which means neither the 50th nor the 51st Amendment revised it. It sets maximum use levels by product category, and for fine fragrance, IFRA category 4, the limit is 0.10 percent in the finished product. Other categories run from 0.016 percent for underarm products up to no restriction at all for category 12, which covers non-skin-contact products such as candles.
The specification half is the part that changed the smell. The Standard requires that “levels of Atranol and Chloroatranol should each be below 100 ppm in Oakmoss extracts.” Separately, the EU prohibited atranol and chloroatranol as substances under Regulation 2017/1410. So a supplier can still sell oakmoss extract, and a perfumer can still use it in a fine fragrance up to 0.10 percent, provided the extract has been purified to remove two specific naturally occurring constituents below detectable levels.
The accurate summary: oakmoss was not banned, it was capped and cleaned. Purified low-atranol oakmoss is a commercial product. It does not smell the same as unpurified oakmoss, which is why classical chypres changed — but “IFRA banned oakmoss” is wrong in both the verb and the agent, since the substance ban came from the European Commission and applied to constituents, not to the extract.
How do raw material supply and cost force reformulation?
More often than regulation does, and with no announcement whatsoever.
Vanilla is the documented case. A peer-reviewed analysis of vanilla price bubbles records prices around $20/kg in the 2008-2010 period, about $80/kg in 2014, rising to roughly $600/kg by 2017 and a record near $600/kg in May 2018, subsequently trading between $600 and $750. The 2014-2018 spike is attributed to rising demand, falling supply, speculation and Cyclone Enawo, which hit Madagascar’s vanilla-growing regions in March 2017. A thirty-fold move in a base material does not leave formulas untouched, and nobody puts out a press release about it.
Political disruption does the same thing faster. The Washington Post reports that Chanel No 19 was reformulated after the 1979 Iranian revolution cut off galbanum supplies — a supply-driven reformulation four decades before the current regulatory wave, and a useful reminder that reformulation is not a modern phenomenon.
Slow-growing woods are a structural version of the same problem. Sandalwood and agarwood cannot be scaled up on a product timetable, and trade in agarwood-producing genera is CITES-regulated. When a brief calls for oud in a globally distributed fragrance, the answer is reconstruction, and the reconstruction changes whenever its components do.
Then there is straightforward cost engineering. A brand under margin pressure can ask for a formula to be re-costed downward, and the fragrance house will deliver a version that smells as close as it can at the new price. No regulation is involved, no announcement is made, and this is very likely the single most common cause of the changes enthusiasts notice.
What happens when a captive molecule is discontinued?
A captive is a molecule made by one fragrance house and available only in that house’s formulas. It is a competitive asset: a rival cannot match an effect they cannot buy.
The vulnerability is obvious. If the house stops producing it — because the plant is repurposed, the volume no longer justifies the line, a feedstock became unavailable, or a new safety assessment made the risk unattractive — every fragrance built on it has to be rebuilt, and no substitute will be exact, because the whole point of a captive was that no substitute existed.
Here the honest answer is that houses do not disclose this. Captive discontinuations are not announced, are not listed, and are visible to outsiders only as an unexplained change in a fragrance that no regulatory change accounts for. Any specific claim that a named fragrance changed because a named captive was withdrawn is, in the absence of a statement from the house, a hypothesis.
How can you tell a reformulation from your own nose or a degraded bottle?
Usually you cannot, with certainty. But the failure modes have different signatures, and the pattern of what changed narrows it considerably.
| Cause | What you would notice | What points away from it |
|---|---|---|
| Regulatory reformulation | A specific material class is quieter or gone — the mossy-bitter green in a chypre, the muguet in a floral — while the overall structure survives. Timing clusters near an amendment compliance deadline | The whole fragrance is weaker rather than one facet; or the change predates any relevant deadline |
| Cost reformulation | Naturals thin out. Less texture, shorter arc, more obviously synthetic-smelling body. Often accompanied by packaging or size changes | One specific note is gone while everything else is intact |
| Supply-driven reformulation | One expensive natural recedes and a reconstruction takes its place; often follows a documented crop failure or price spike | Nothing correlates with a known supply event |
| Oxidized bottle | The top notes are the problem: citrus goes sour, waxy or turpentine-like, while the base is roughly intact. Worse in a part-used bottle, a warm bathroom, or one stored in light | A brand-new sealed bottle behaves the same way |
| Your own nose and expectation | You cannot reproduce the difference blind. The old bottle smells different when you do not know which is which | Two people who have never smelled the old version independently describe the same specific absence |
The single most useful discipline is the one perfumers use on themselves: smell blind. Have someone else spray two blotters from an old bottle and a new one, unmarked, and see whether you can sort them. Most people, most of the time, cannot — and that result is information, not a failure.
The second most useful discipline is to distrust the note list. A published note pyramid is marketing copy and is frequently carried over unchanged through several reformulations, because it was never a description of the formula. See what a published note pyramid is really for.
How reformulation actually happens, step by step
- A trigger arrives. An IFRA amendment is notified, an EU instrument is published, a supplier raises a price, a crop fails, or a brand asks for a cheaper version.
- The house screens its portfolio. Regulatory systems flag every formula carrying the affected material above the new limit — for an amendment touching dozens of materials, thousands of formulas per house.
- Affected formulas are triaged. Some need a dose reduction and nothing else. Some need the material replaced. Some cannot be saved in their current shape.
- A perfumer rebuilds. Usually not the original perfumer, and often decades later. The target is to match the existing product, not to improve it.
- The new version is compared against a retained reference. Houses keep samples of the original as the benchmark, which is why reformulations are usually close rather than arbitrary.
- The brand approves, or does not. A brand that dislikes every option may accept a change it would rather not, because the alternative is not selling in that market.
- The new formula phases in. Old stock continues to sell alongside new stock, which is why two bottles bought the same week can differ.
- Nothing is announced. There is no regulatory obligation to disclose a formula change, and the note list on the box usually does not change.
Which reformulation claims are wrong?
“IFRA banned oakmoss”
What is claimed: IFRA prohibited oakmoss, destroying the chypre family.
What the evidence shows: The IFRA Standard for oakmoss extracts is a restriction plus specification. Fine fragrance (category 4) may contain up to 0.10 percent, and the specification requires atranol and chloroatranol each below 100 ppm in the extract. Separately, the European Commission prohibited atranol and chloroatranol as substances under Regulation 2017/1410.
What people wrongly conclude: That oakmoss is unavailable and that IFRA banned it. Purified oakmoss is a commercial product; the substance ban came from the Commission and applied to two constituents, not to the extract.
“IFRA is a law and IFRA limits are legal limits”
What is claimed: IFRA Standards have the force of regulation.
What the evidence shows: IFRA is the industry trade association’s self-regulatory program, binding on members. The Washington Post put member coverage at an estimated 80 to 90 percent of the industry. Regulation (EC) No 1223/2009 is the binding law in the EU. In the US, the FDA had not issued MoCRA fragrance allergen regulations as of early 2026.
What people wrongly conclude: That an IFRA limit is enforceable by a government, or that a small non-member producer is breaking the law by exceeding one. Neither is true, though exceeding an IFRA limit will usually end a commercial relationship.
“The EU limits how much allergen a perfume can contain”
What is claimed: Annex III caps allergen concentrations.
What the evidence shows: For the declared fragrance allergens, Annex III mostly sets labelling thresholds — 0.001 percent leave-on, 0.01 percent rinse-off — and industry analysis notes that the final concentration of these allergens in the finished product is not restricted by the Regulation itself. IFRA sets the concentration ceilings.
What people wrongly conclude: That a long allergen list on a box means the product is near a legal limit. It means those substances are present above a disclosure threshold, which for a leave-on product is one part in a hundred thousand.
“Lilial was restricted for causing allergies”
What is claimed: Lilial went the way of Lyral, as a sensitizer.
What the evidence shows: Butylphenyl methylpropional was added to Annex II by Regulation (EU) 2021/1902 on the basis of a CMR category 1B classification for reproductive toxicity, applying from 1 March 2022 with no sell-off period. It had previously been an Annex III labelled allergen, but the ban came through the CMR route.
What people wrongly conclude: That all fragrance restrictions run through skin sensitization. They do not, and the CMR route is faster and harsher: no transition, no sell-off, products off shelves.
“My bottle was reformulated”
What is claimed: A fragrance that smells different from memory has been changed.
What the evidence shows: Top notes are the least stable part of a composition, and oxidation in an opened bottle reliably degrades them first, which reads as exactly the same symptom people attribute to reformulation. Reformulations do happen and are not announced, so the claim is often correct — but a part-used bottle stored warm is the more common explanation, and almost nobody tests it blind.
What people wrongly conclude: That the difference proves a formula change. It proves a difference. Blind comparison against a fresh bottle is the only way to separate the two, and even then you are comparing two bottles, not two formulas.
The honest limits of this article
You cannot verify a reformulation from outside. Houses have no obligation to announce formula changes and generally do not; the note list on the packaging is marketing copy and usually survives unchanged; and even a gas chromatography trace of two bottles would show differences caused by age and storage as well as by formula. So every claim of the form “fragrance X was reformulated in year Y because of Z” is inference unless a house has said so. The named examples here — Chanel No 19 and galbanum, Guerlain Mitsouko and Thierry Wasser’s reworking — come from newspaper reporting rather than company statements, and should be read at that level of confidence. Regulatory dates and limits, by contrast, are drawn from the instruments themselves and from IFRA’s notification documents, and are as solid as anything here gets.
What to do with this as a buyer
Three practical conclusions.
Stop treating reformulation as a moral event. A formula that has been rebuilt to survive a category limit is not a cheapened product, and a formula rebuilt to hit a lower cost target might be. Those are different things with the same symptom, and the only signal that distinguishes them is which part of the fragrance changed: one missing facet points to regulation or supply, uniform thinness points to cost.
What our own catalogue shows
You can watch the vocabulary shift in our own listing copy, with a caveat attached. Of the 3,832 bottles we list, about 43 mention oakmoss. Lyral, hydroxyisohexyl 3-cyclohexene carboxaldehyde and lilial appear in none — a fact about copywriting, not chemistry. Restricted materials were never the sort of thing marketing copy named, so their absence tells you nothing about any formula. What the oakmoss count shows is that a material can stay in the language of perfumery long after its use has been capped, which is how a note list survives a reformulation unchanged.
How much of what is on sale today predates these restrictions is a question we cannot answer from our own catalogue. A product listing records a name, a size, a price and a code — never a release year. Any figure would have to be assembled from marketing prose, which is exactly the kind of number this article argues you should not trust. A great many fragrances sold now under a pre-2000 name have been rebuilt at least once, and the bottle will not tell you.
Bottles to try this on
Buy the current version if you like the current version. Chasing a vintage bottle means buying an unknown storage history, and an oxidized original is objectively further from the perfumer’s intent than a compliant reformulation. If you want to hear how a classical chypre-adjacent structure reads now, Guerlain Shalimar and Chanel No 5 are both current-production references built on materials that have been through several regulatory cycles, and both still work.
Recognize which fragrances are structurally exposed. A fragrance whose identity rests on one restricted natural is fragile; one built on synthetics with stable supply is not. A woody-amber composition such as Terre d’Hermès or Dior Sauvage Eau de Parfum is comparatively insulated, because the materials carrying it are manufactured to specification. An oud-led fragrance like Tom Ford Oud Wood depends on a reconstruction whose components can be revised at any time. And a single-material fragrance such as Escentric Molecules Molecule 01 is the extreme case in both directions: nothing to cheapen, and nowhere to hide if that one molecule is ever restricted.
Related reading
- the production chain behind a fragrance — six years in the field, a few hours on the line
- the real trade-off between naturals and synthetics — behavior, supply and the quality myth
- the five extraction methods that matter — five methods, and what each one leaves behind
- what a perfumer actually does all day — briefs, benchmarks, submissions and formula cards
- what Intense, Elixir and Le Parfum really signal — sorting versions of one fragrance from separate fragrances
Common questions
Why do perfumes get reformulated?
Four main reasons: a raw material was restricted or banned, a raw material became expensive or unavailable, a captive molecule was discontinued, or the brand asked for a cheaper formula. Only the first is regulatory. Cost-driven reformulation is probably the most common and is never announced.
Did IFRA ban oakmoss?
No. The IFRA Standard for oakmoss extracts is a restriction with a specification, and the version published in IFRA’s Standards Library is still the Amendment 49 text of 2020. Fine fragrance may contain up to 0.10 percent, and the extract must contain atranol and chloroatranol each below 100 ppm. Separately the European Commission banned those two constituents as substances in 2017. Purified oakmoss remains a commercial material.
Is IFRA a law?
No. IFRA Standards are the fragrance industry’s self-regulatory program, binding on members and in practice on anyone whose customers require an IFRA certificate. Reporting in 2021 put member coverage at an estimated 80 to 90 percent of the industry. The binding law in the EU is Regulation (EC) No 1223/2009.
What is the current IFRA amendment?
The 51st Amendment, notified 30 June 2023, is the one in force; its final compliance deadline for existing creations was 30 October 2025. The 52nd Amendment’s consultation closed on 12 June 2026 and IFRA published its End of Consultation Letter on 31 August 2026, with notification expected in January 2027.
Why was Lilial banned?
Through the CMR route rather than the skin-allergy route. Butylphenyl methylpropional was added to Annex II of the EU Cosmetics Regulation by Regulation (EU) 2021/1902 as entry 1666, among substances classified as CMR, and the ban applies from 1 March 2022 with no sell-off period. That is why some products were withdrawn rather than reformulated.
Does the EU limit how much allergen a perfume can contain?
Mostly no. For the declared fragrance allergens, Annex III sets labelling thresholds of 0.001 percent in leave-on and 0.01 percent in rinse-off products. Industry analysis notes the final concentration in the finished product is not restricted by the Regulation. IFRA Standards set the concentration ceilings.
How can I tell if a perfume has been reformulated?
From outside, usually you cannot be certain. Look at what changed: one missing facet suggests regulation or supply, uniform thinness suggests cost, and a sour or turpentine-like top with an intact base suggests an oxidized bottle. Then test blind, because most people cannot sort unmarked blotters reliably.
Is a reformulated perfume worse?
Not necessarily. Houses rebuild against a retained sample of the original, so the target is to match rather than to change. A regulatory reformulation can be close; a cost reformulation is usually thinner. An oxidized vintage bottle is often further from the perfumer’s intent than the current compliant version.
What is a captive molecule?
A molecule made by one fragrance house and available only in its own formulas, which prevents rivals from matching a particular effect. If the house stops producing it, every fragrance built on it has to be rebuilt with no exact substitute. Houses do not announce captive discontinuations, so outsiders cannot track them.
Do brands have to say when they change a formula?
No. There is no obligation to announce a formula change, and published note lists are marketing copy that usually survives unchanged through reformulations. Ingredient labels list declarable allergens above threshold, which can shift, but they do not describe the formula.





